Development and prospective validation of a risk score model in guiding individualized concurrent chemoradiotherapy in stage II nasopharyngeal carcinoma in intensity‐modulated radiotherapy era - Yang, Shan‐Shan; Pang, Ya‐Jun; Wang, Zhi‐Qiang; Zhang, Bao‐Yu; Liu, Zhi‐Qiao; Chen, En‐Ni; OuYang, Pu‐Yun; Xie, Fang‐Yun (Cancer medicine (Malden, MA), 2022)
Keywords: Cancer therapies; Chemoradiotherapy; Chemoradiotherapy - adverse effects; Chemoradiotherapy - methods; Chemotherapy; Clinical Cancer Research; concurrent chemoradiotherapy; Dehydrogenases; DNA viruses; Epstein-Barr virus; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; intensity‐modulated radiotherapy; L-Lactate dehydrogenase; Lactic acid; Lymphatic system; Magnetic resonance imaging; Medical prognosis; Multivariate analysis; Nasopharyngeal carcinoma; Nasopharyngeal Carcinoma - pathology; Nasopharyngeal Neoplasms - pathology; Patients; Plasma; Radiation therapy; Radiotherapy, Intensity-Modulated - adverse effects; Radiotherapy, Intensity-Modulated - methods; Retrospective Studies; Risk Factors; Risk groups; Software; Statistical analysis; Survival; Throat cancer; Tomography; tumor burden; Tumors; intensity-modulated radiotherapy; nasopharyngeal carcinoma; tumor burden; concurrent chemoradiotherapy